Return on average equity - 5 year average | 20.10 |
Net Income/employee - trailing 12 month | 8,71,484.10 |
Revenue/employee - most recent fiscal year | 1,37,31,110.00 |
Return on investment - most recent fiscal year | 24.44 |
Return on average assets - most recent fiscal year | 15.66 |
Receivables turnover - most recent fiscal year | 9.79 |
Return on investment - trailing 12 month | 11.44 |
Return on average assets - trailing 12 month | 6.99 |
Inventory turnover - most recent fiscal year | 3.23 |
Inventory turnover - trailing 12 month | 2.52 |
Revenue/employee - trailing 12 month | 1,57,92,680.00 |
Return on average assets - 5 year average | 11.78 |
Net Income/employee - most recent fiscal year | 17,11,818.00 |
Return on average equity - trailing 12 month | 12.28 |
Receivables turnover - trailing 12 month | 10.63 |
Asset turnover - most recent fiscal year | 1.26 |
Asset turnover - trailing 12 month | 1.27 |
Return on average equity - most recent fiscal year | 24.84 |
Return on investment - 5 year average | 19.62 |
Astrazeneca Pharma India Dividend Astrazeneca Pharma India Bonus Astrazeneca Pharma India News Astrazeneca Pharma India AGM Astrazeneca Pharma India Rights Astrazeneca Pharma India Splits Astrazeneca Pharma India Board Meetings Astrazeneca Pharma India Shareholdings Astrazeneca Pharma India Profit Loss Astrazeneca Pharma India Balance Sheet Astrazeneca Pharma India Cashflow Astrazeneca Pharma India Q1 Results Astrazeneca Pharma India Q2 Results Astrazeneca Pharma India Q3 Results Astrazeneca Pharma India Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks